Evidence map›Paper›PMID 24828901›Full record

ReviewLancet (London, England)2014

Current status of rabies and prospects for elimination.

Anthony R Fooks, Ashley C Banyard, Daniel L Horton, Nicholas Johnson, Lorraine M McElhinney, Alan C Jackson

Open access · bronzeAbstract readReview
In one paragraph

Review in Lancet (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 271 papers.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 565 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Anthony R FooksAnimal Health and Veterinary Laboratories Agency (AHVLA, Weybridge), New Haw, Addlestone, UK; WHO Communicable Disease Surveillance and Response Collaborating Centre for the Characterisation of Rabies and Rabies-related Viruses, Addlestone, Weybridge, UK; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK; National Consortium for Zoonosis Research, University of Liverpool, Leahurst, Neston, UK. Electronic address: Tony.Fooks@ahvla.gsi.gov.uk.
Ashley C BanyardAnimal Health and Veterinary Laboratories Agency (AHVLA, Weybridge), New Haw, Addlestone, UK; WHO Communicable Disease Surveillance and Response Collaborating Centre for the Characterisation of Rabies and Rabies-related Viruses, Addlestone, Weybridge, UK.
Daniel L HortonAnimal Health and Veterinary Laboratories Agency (AHVLA, Weybridge), New Haw, Addlestone, UK; WHO Communicable Disease Surveillance and Response Collaborating Centre for the Characterisation of Rabies and Rabies-related Viruses, Addlestone, Weybridge, UK.
Nicholas JohnsonAnimal Health and Veterinary Laboratories Agency (AHVLA, Weybridge), New Haw, Addlestone, UK; WHO Communicable Disease Surveillance and Response Collaborating Centre for the Characterisation of Rabies and Rabies-related Viruses, Addlestone, Weybridge, UK.
Lorraine M McElhinneyAnimal Health and Veterinary Laboratories Agency (AHVLA, Weybridge), New Haw, Addlestone, UK; WHO Communicable Disease Surveillance and Response Collaborating Centre for the Characterisation of Rabies and Rabies-related Viruses, Addlestone, Weybridge, UK; National Consortium for Zoonosis Research, University of Liverpool, Leahurst, Neston, UK.
Alan C JacksonDepartments of Internal Medicine (Neurology) and of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Animal and Plant Health Agency · GBVeterinary Medicines Directorate · GBNational Consortium for Zoonosis Research · GBUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rabies is one of the most deadly infectious diseases, with a case-fatality rate approaching 100%. The disease is established on all continents apart from Antarctica; most cases are reported in Africa and Asia, with thousands of deaths recorded annually. However, the estimated annual figure of almost 60,000 human rabies fatalities is probably an underestimate. Almost all cases of human rabies result from bites from infected dogs. Therefore, the most cost-effective approach to elimination of the global burden of human rabies is to control canine rabies rather than expansion of the availability of human prophylaxis. Mass vaccination campaigns with parenteral vaccines, and advances in oral vaccines for wildlife, have allowed the elimination of rabies in terrestrial carnivores in several countries worldwide. The subsequent reduction in cases of human rabies in such regions advocates the multidisciplinary One Health approach to rabies control through the mass vaccination of dogs and control of canine populations.

Indexed as

Rabies VaccinesAnimalsCentral Nervous SystemDisease EradicationDisease VectorsDogsForecastingGlobal HealthHumansLife Cycle StagesRabiesVaccinationZoonosesRabies Vaccines

Identifiers

PMID24828901
PMCPMC7159301
OpenAlexW2114256073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.